NewGyn (1 x 2ml)

NewGyn

Intimate injectable

Polynucleotide and hyaluronic acid gel for vulvo-vaginal area

Class III CE Marked medical device for intradermal infiltration in the vulvo Vaginal area.
Manufactured by Mastelli S.r.l. under quality management systems compliant with European medical device regulations, including ISO 13485 for medical devices.
Listed within Mastelli’s Aesthetic Medicine & Dermocosmetics PN HPT® portfolio as a gel containing Polynucleotides HPT, Hyaluronic Acid and Mannitol for intradermal infiltrations in a 2 ml pre Filled syringe.

Class III CE Marked medical device for intradermal infiltration in the vulvo Vaginal area.
Manufactured by Mastelli S.r.l. under quality management systems compliant with European medical device regulations, including ISO 13485 for medical devices.
Listed within Mastelli’s Aesthetic Medicine & Dermocosmetics PN HPT® portfolio as a gel containing Polynucleotides HPT, Hyaluronic Acid and Mannitol for intradermal infiltrations in a 2 ml pre Filled syringe.
Subject to clinical evaluation, risk management and post Market surveillance in accordance with applicable EU and regional medical device legislation.

Description

NewGyn is a Class III CE-marked, isotonic viscoelastic gel containing PN-HPT® (highly purified polynucleotides), non-cross-linked hyaluronic acid and mannitol, supplied in a 2 ml pre-filled syringe with two 30G ½ needles. Developed by Mastelli for intimate gynaecological and aesthetic use, it is injected intradermally into the vulvo-vaginal and labial tissues to enhance turgor and trophism of the skin layers and genital area mucosae. By promoting tissue regeneration, hydration and improved elasticity, NewGyn is used to address symptoms of vulvo-vaginal atrophy such as dryness, itching, soreness, dyspareunia and loss of tone, as well as for labia and vulvar rejuvenation.

Bnefits

Enhances turgor and trophism of vulvar and vulvo-vaginal skin and mucosa, improving tone and tissue quality.
Improves vaginal and vulvar hydration, helping relieve dryness, irritation and soreness in the intimate area.
Promotes tissue regeneration by stimulating fibroblast activity and supporting collagen and elastin synthesis through PN-HPT®.
Non-cross-linked hyaluronic acid provides deep, long-lasting hydration and contributes to improved firmness and elasticity.
Mannitol acts as an antioxidant and protects hyaluronic acid from enzymatic and oxidative degradation, prolonging its activity.
Reduces symptoms associated with vulvo-vaginal atrophy such as itching, dyspareunia and loss of elasticity.
Supports labia and vulvar rejuvenation, improving the aesthetic appearance and consistency of intimate tissues.
Minimally invasive injectable procedure that can be tailored in cycles of sessions with limited downtime.

Indications

Enhancement of turgor and trophism of skin layers and genital area mucosae in the vulvo-vaginal region.
Vulvo-vaginal atrophy-related symptoms, including dryness, burning, irritation and discomfort.
Vulvar pain and dyspareunia associated with atrophic, dehydrated or fragile intimate tissues.
Itchiness and loss of elasticity in the vulvar and vestibular areas.
Labia rejuvenation, including improved elasticity and correction of volume/tone deficits following ageing, childbirth or surgery.